Stanciu Anca, Florica Cecilia Enescu, Zota Alexandra, Tebeica Tiberiu, Leventer Mihaela, Bobirca Florin
Chirurgia (Bucur). 2020 Jan-Feb;115(1):69-79. doi: 10.21614/chirurgia.115.1.69.
Basal cell carcinoma (BCC) and Squamous cell carcinoma (SCC) are the most frequent skin cancers with a continuous increasing incidence and a cause of economic impact. Mohs micrographic surgery (MMS) is known as the gold-standard of treatment of non-melanoma skin cancer. The files of the patients treated with MMS were analysed during a 6 year period (2014-2019) and demographic information was extracted in addition to the information on tumor histology, localization of tumors, number of stages required for a complete removal of the tumors, and the evolution of the patients. We also analysed the information regarding the number and type of reconstructions performed. Over the course of 6 years, 1,356 cutaneous tumors were treated in our clinic by means of MMS. BCC represented 80.5%, SCC 17.6%, and other tumors such as melanoma in situ, DFSP, Extramammary Paget's Disease - being 1.9% of the number of other treated tumors. During the period under review, only 4 cases of post-Mohs Micrographic Surgery recurrence have been recorded, with a cure rate of over 99.7%. Mohs micrographic surgery is an efficient treatment method in removing cutaneous carcinoma as well as tumors with special indications with a low recurrence rate therefore reducing the need of successive surgical interventions.
基底细胞癌（BCC）和鳞状细胞癌（SCC）是最常见的皮肤癌，其发病率持续上升，且造成了经济影响。莫氏显微外科手术（MMS）是治疗非黑色素瘤皮肤癌的金标准。我们分析了在6年期间（2014 - 2019年）接受MMS治疗的患者档案，除了肿瘤组织学、肿瘤定位、完全切除肿瘤所需的阶段数以及患者病情演变等信息外，还提取了人口统计学信息。我们还分析了有关所进行的重建手术的数量和类型的信息。在6年的时间里，我们诊所通过MMS治疗了1356例皮肤肿瘤。其中BCC占80.5%，SCC占17.6%，其他肿瘤如原位黑色素瘤、隆突性皮肤纤维肉瘤、乳房外佩吉特病占其他治疗肿瘤数量的1.9%。在审查期间，仅记录到4例莫氏显微外科手术后复发病例，治愈率超过99.7%。莫氏显微外科手术是一种有效的治疗方法，可用于切除皮肤癌以及有特殊指征的肿瘤，复发率低，因此减少了后续手术干预的必要性。
